Key result
Hepatic steatosis in non-diabetic patients was associated with worse metabolic profiles, including significant differences in triglycerides (p=0.002) and HDL (p=0.019) among lean patients.
Why the study?
Few studies have evaluated the potential association between different grades of hepatic steatosis and clinical patterns in a non-diabetic population.
Does the degree of hepatic steatosis assessed by ultrasound correlate with metabolic alterations and kidney function decline in non-diabetic individuals?
Cross-Sectional (n=223)
Does the degree of hepatic steatosis assessed by ultrasound correlate with metabolic alterations and kidney function decline in non-diabetic individuals?
The degree of hepatic steatosis on ultrasound correlates with glucose and lipid metabolism disorders, as well as reduced kidney function, in non-diabetic patients.
Supports graded steatosis-metabolic links in non-diabetics; leaves open causality and clinical utility of ultrasound staging.
Introduction: Several studies have demonstrated a positive correlation between severe hepatic steatosis and metabolic alterations; however, few studies have addressed the potential association between different grades of steatosis and clinical patterns in a non-diabetic population. Methods: We conducted a cross-sectional study of 223 non-diabetic individuals. The severity of steatosis was assessed using B-mode ultrasound. We analyzed lipid and glucose profiles according to the severity of hepatic steatosis. Estimated glomerular filtration rate (eGFR) values were also recorded to investigate the potential impact of steatosis on kidney function. Results: Patients with steatosis were found to have higher insulinemia and mean values of fasting plasma glucose compared to patients without steatosis. A significant decrease in high-density lipoprotein level was observed only in patients with severe or moderate steatosis. All grades of steatosis were associated with increased triglyceride levels, which were more significant in severe steatosis. Subgroup analysis by body mass index demonstrated a significant difference between lean patients with steatosis and lean patients without steatosis for triglycerides (p = 0.002) and high-density lipoprotein levels (p = 0.019). Finally, patients diagnosed with steatosis demonstrated a higher prevalence of estimated glomerular filtration rate < 90 ml/min. Conclusion: The degree of steatosis diagnosed at ultrasound may predict glucose or lipid metabolism disorders and a decline in kidney function in a non-diabetic population.
No takes yet. Share an insight, caveat, or question.
Villani et al. (2022) conducted a cross-sectional in Hepatic steatosis (n=223). Hepatic steatosis vs. No steatosis was evaluated on Lipid and glucose profiles and estimated glomerular filtration rate. Hepatic steatosis in non-diabetic patients was associated with worse metabolic profiles, including significant differences in triglycerides (p=0.002) and HDL (p=0.019) among lean patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: